documents: FDA-2013-D-1275-0014
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1275-0014 | FDA | FDA-2013-D-1275 | General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products Guidance for Industry; DRAFT GUIDANCE | Other | Guidance | 2022-09-08T04:00:00Z | 2022 | 9 | 2022-09-08T04:00:00Z | 2022-12-08T04:59:59Z | 2026-01-03T12:21:42Z | 1 | 0 | 09000064852b7e96 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref